You are viewing the public part of the archive. Login or request access to view more content.
Displaying 1-7 of 7 results
00:48:58
2008_106
Daria Hazuda from MSD explains the virology of HIV and talks about the past clinical studies on ARV, in particular integrase inhibitors, which she has been involved in. She also reflects on HIV as an exceptional virus and how to influence a new generation of HIV researchers.
2008_106
00:08:56
2002_16
Gary Nabel, from the Vaccine Research Center (VRC) talks about engaging the scientific community and health personnel in HIV research and about the importance of international conferences to create these kinds of collaborations.
2002_16
00:07:02
2002_15
Marc Girard who is the general director of the Mérieux Foundation, talks about Cent Gardes and the collaboration between France and the USA, mainly represented by the Pasteur Institute and NIH, and about why HIV is such a complicated virus to find a vaccine for.
2002_15
00:17:37
2002_10
Luc Montagnier talks about the complex virology of HIV which makes the AIDS vaccine development so difficult. He also talks about the economic and cultural advantages of using traditional medicine as a part of the ARV therapy in developing countries.
2002_10
00:46:00
AIDS - From Panic To Silence
The primary focus of this documentary is on the history of how the AIDS epidemic started in San Francisco, Los Angeles and New York in 1981. Many different stories are told about people affected or surrounded by HIV and AIDS in the early years of the epidemic.
1998_aids_from_panic_to_silence
00:13:40
1992_7
Robin Weiss, a British Molecular Biologist and Professor of Viral Oncology at University College London, talks about the scientific contribution of small countries like Sweden, interdisciplinary collaborations in HIV research and HIV vaccines.
1992_7
00:12:27
1988_105
Dr Luc Montagnier and Dr Lars Olof Kallings in Montagnier’s office and laboratory at the Pasteur Institute in Paris. They talk about the HIV virus and the difficulties and possibilities of finding effective antiretroviral drug combinatoions in the future.
1988_105